These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10753034

  • 1. Nitric oxide and vascular responses in Type I diabetes.
    Chan NN, Vallance P, Colhoun HM.
    Diabetologia; 2000 Feb; 43(2):137-47. PubMed ID: 10753034
    [Abstract] [Full Text] [Related]

  • 2. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K, Sármán B, Jermendy G, Somogyi A.
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [Abstract] [Full Text] [Related]

  • 3. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.
    Traub O, Van Bibber R.
    West J Med; 1995 May; 162(5):439-45. PubMed ID: 7785258
    [Abstract] [Full Text] [Related]

  • 4. The role of nitric oxide in the development of diabetic angiopathy.
    Santilli F, Cipollone F, Mezzetti A, Chiarelli F.
    Horm Metab Res; 2004 May; 36(5):319-35. PubMed ID: 15156413
    [Abstract] [Full Text] [Related]

  • 5. Endothelial dysfunction in diabetes mellitus.
    Cosentino F, Lüscher TF.
    J Cardiovasc Pharmacol; 1998 May; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [Abstract] [Full Text] [Related]

  • 6. Endothelial dysfunction, atherosclerosis and diabetes.
    Najemnik C, Sinzinger H, Kritz H.
    Acta Med Austriaca; 1999 May; 26(5):148-53. PubMed ID: 11512191
    [Abstract] [Full Text] [Related]

  • 7. Diabetic angiopathy: tracking down the culprits.
    Tooke JE, Shore AC, Cohen RA, Kluft C.
    J Diabetes Complications; 1996 May; 10(3):173-81. PubMed ID: 8807468
    [No Abstract] [Full Text] [Related]

  • 8. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T, Kunt T.
    Exp Diabesity Res; 2004 May; 5(1):51-64. PubMed ID: 15198371
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand factor in diabetic angiopathy.
    Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [Abstract] [Full Text] [Related]

  • 10. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P.
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [Abstract] [Full Text] [Related]

  • 11. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A.
    Acta Med Indones; 2006 Sep; 38(1):33-41. PubMed ID: 16479030
    [Abstract] [Full Text] [Related]

  • 12. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A, Beckman JA, Schmidt AM, Creager MA.
    Circulation; 2006 Aug 08; 114(6):597-605. PubMed ID: 16894049
    [Abstract] [Full Text] [Related]

  • 13. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
    Bucala R, Tracey KJ, Cerami A.
    J Clin Invest; 1991 Feb 08; 87(2):432-8. PubMed ID: 1991829
    [Abstract] [Full Text] [Related]

  • 14. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ.
    Diabetologia; 2002 Jul 08; 45(7):1004-10. PubMed ID: 12136399
    [Abstract] [Full Text] [Related]

  • 15. [Endothelial dysfunction and diabetes: possible role in kidney damage].
    Tesauro M, Leo R, Lauro R, Cardillo C.
    G Ital Nefrol; 2009 Jul 08; 26 Suppl 46():62-70. PubMed ID: 19644821
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Glucose metabolism in vascular endothelial cells].
    Yokota C, Okuda Y.
    Nihon Rinsho; 2002 Jul 08; 60 Suppl 7():324-30. PubMed ID: 12238067
    [No Abstract] [Full Text] [Related]

  • 19. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.
    Bucci M, Roviezzo F, Brancaleone V, Lin MI, Di Lorenzo A, Cicala C, Pinto A, Sessa WC, Farneti S, Fiorucci S, Cirino G.
    Arterioscler Thromb Vasc Biol; 2004 Apr 08; 24(4):721-6. PubMed ID: 14962949
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.